TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 11 Jun 2021, 11:40 BST

Official UK procurement notice

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)

Official notice

Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)

Framework agreementGoodsNegotiated without publication of a contract notice
Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)Yorkshire & Humber (UKE)
+8 moreEast Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)Scotland (UKM)Northern Ireland (UKN)
Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue
Awarded 10 Jun 2021

What is being bought

Published requirement description

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

CPV: Immunoglobulins

The lotProcurement structure

single lot · no lot value published
Lot #1NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)

NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.

Delivery: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East, South West, Scotland, Northern Ireland · ITT lists Purchasing Points. Framework intended for use by the NHS in England, Scotland Northern Ireland, Dept of Health & Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above
Extensions: Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.
33651520 Immunoglobulins

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
  • Price
What this means for your bid
  • “NHS Framework Agreement for the Supply of Human Normal Immunoglobulin…” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record
Procedure method
Negotiated without publication of a contract notice
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
11 Jun 2021, 11:40 BST
Last source update
11 Jun 2021, 11:40 BST
Authority reference
CM/PHS/21/5642
FTS notice number
2021/S 000-013184
Classification (CPV)
Immunoglobulins
Delivery area
North East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)
+3 moreSouth West (UKK)Scotland (UKM)Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-02baf3 Find a Tender
Why no open competition

Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive

Published justification

An urgent need to secure additional supply of Human Normal Immunoglobulin as a result of the ongoing global supply shortages

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 1admitted to the panel · see the list ↓
Contracts signed 1latest 10 Jun 2021

1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Contract 013184-2021-1

    Signed
    10 Jun 2021
    Value
    £17,595,000
    Status
    active

Contracting authority & participating public bodies

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authorityNHS & healthcareMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 2nd Floor, Rutland House, Runcorn, UK, WA7 2ESContact name, email

Dispute resolution & review bodies

  • The High CourtReview body London

Framework contractors & participating bidders

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.